We provide you with 20 years of free, institutional-grade data for CWBR stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of CWBR. Explore the full financial landscape of CWBR stock.
| Reported Date | CIK | Ticker | Type |
|---|
CohBar, Inc(NASDAQ:CWBR) 
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopa...
Website: http://www.cohbar.com
Founded: 2007
Full Time Employees: 12
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about CWBR stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.